• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在人类脂肪细胞的脂肪生成和脂肪因子产生过程中,起主导作用的是糖皮质激素受体,而非盐皮质激素受体。

The glucocorticoid receptor, not the mineralocorticoid receptor, plays the dominant role in adipogenesis and adipokine production in human adipocytes.

作者信息

Lee M-J, Fried S K

机构信息

Section of Endocrinology, Diabetes and Nutrition, Department of Medicine, Boston University School of Medicine, Boston, MA, USA.

出版信息

Int J Obes (Lond). 2014 Sep;38(9):1228-33. doi: 10.1038/ijo.2014.6. Epub 2014 Jan 16.

DOI:10.1038/ijo.2014.6
PMID:24430397
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4321810/
Abstract

BACKGROUND

Both the glucocorticoid receptor (GR) and the mineralocorticoid receptor (MR) are expressed in adipose tissue and assumed to mediate cortisol actions on adipose tissue. The relative significance of the two receptors in mediating glucocorticoid regulation of adipogenesis and adipokine expression in human adipocytes has not been addressed.

METHODS

We investigated the differential roles of the GR and MR in mediating glucocorticoid actions on adipogenesis and adipokine production using RNA interference in primary cultures of human preadipocytes and adipocytes.

RESULTS

Both types of receptors are expressed, but levels of GR were several hundred fold higher than MR in both human preadipocytes and adipocytes. As expected, cortisol added during adipogenesis increased the differentiation of human preadipocytes. Silencing of GR, but not MR, blocked these proadipogenic actions of cortisol. In differentiated human adipocytes, addition of cortisol increased leptin and adiponectin, while suppressing interleukin-6 (IL-6), messenger RNA levels and protein secretion. Knockdown of GR by 65% decreased leptin and adiponectin while increasing IL-6 production. In addition, GR silencing blocked the effects of cortisol on adipokine expression. In contrast, although MR knockdown increased leptin, it did not affect adiponectin and IL-6 expression.

CONCLUSION

Our data demonstrate that although both GR and MR have roles in regulating leptin expression, GR plays more important roles in mediating the actions of cortisol to regulate adipogenesis and adipokine production in human adipocytes.

摘要

背景

糖皮质激素受体(GR)和盐皮质激素受体(MR)均在脂肪组织中表达,并被认为介导皮质醇对脂肪组织的作用。这两种受体在介导糖皮质激素对人脂肪细胞脂肪生成和脂肪因子表达的调节中的相对重要性尚未得到探讨。

方法

我们使用RNA干扰技术,在人前脂肪细胞和脂肪细胞的原代培养物中研究了GR和MR在介导糖皮质激素对脂肪生成和脂肪因子产生的作用中的不同作用。

结果

两种受体均有表达,但在人前脂肪细胞和脂肪细胞中,GR的水平均比MR高数百倍。正如预期的那样,在脂肪生成过程中添加皮质醇可增加人前脂肪细胞的分化。GR的沉默而非MR的沉默阻断了皮质醇的这些促脂肪生成作用。在分化的人脂肪细胞中,添加皮质醇可增加瘦素和脂联素,同时抑制白细胞介素-6(IL-6)的信使RNA水平和蛋白质分泌。GR敲低65%会降低瘦素和脂联素水平,同时增加IL-6的产生。此外,GR沉默阻断了皮质醇对脂肪因子表达的影响。相比之下,尽管MR敲低会增加瘦素,但它不影响脂联素和IL-6的表达。

结论

我们的数据表明,尽管GR和MR在调节瘦素表达中均起作用,但GR在介导皮质醇调节人脂肪细胞脂肪生成和脂肪因子产生的作用中发挥更重要的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7734/4321810/3bd59352a39e/nihms547863f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7734/4321810/7fd11ab88ee6/nihms547863f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7734/4321810/23321b9045e2/nihms547863f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7734/4321810/8debc2082988/nihms547863f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7734/4321810/3bd59352a39e/nihms547863f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7734/4321810/7fd11ab88ee6/nihms547863f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7734/4321810/23321b9045e2/nihms547863f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7734/4321810/8debc2082988/nihms547863f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7734/4321810/3bd59352a39e/nihms547863f4.jpg

相似文献

1
The glucocorticoid receptor, not the mineralocorticoid receptor, plays the dominant role in adipogenesis and adipokine production in human adipocytes.在人类脂肪细胞的脂肪生成和脂肪因子产生过程中,起主导作用的是糖皮质激素受体,而非盐皮质激素受体。
Int J Obes (Lond). 2014 Sep;38(9):1228-33. doi: 10.1038/ijo.2014.6. Epub 2014 Jan 16.
2
The balance between gluco- and mineralo-corticoid action critically determines inflammatory adipocyte responses.糖皮质激素和盐皮质激素作用之间的平衡对炎症性脂肪细胞反应具有决定性作用。
J Endocrinol. 2010 Feb;204(2):153-64. doi: 10.1677/JOE-09-0292. Epub 2009 Nov 25.
3
Reply to Armani et al. Can cortisol stimulate adipogenesis without the glucocorticoid receptor?对阿玛尼等人的回应:皮质醇能否在没有糖皮质激素受体的情况下刺激脂肪生成?
Int J Obes (Lond). 2014 Dec;38(12):1578-9. doi: 10.1038/ijo.2014.71. Epub 2014 May 2.
4
Mineralocorticoid vs glucocorticoid receptors: solo players or team mates in the control of adipogenesis?盐皮质激素受体与糖皮质激素受体:脂肪生成调控中的单打独斗者还是团队伙伴?
Int J Obes (Lond). 2014 Dec;38(12):1580-1. doi: 10.1038/ijo.2014.68. Epub 2014 Apr 30.
5
Postnatal triglyceride accumulation is regulated by mineralocorticoid receptor activation under basal and stress conditions.产后甘油三酯的积累受基础和应激条件下盐皮质激素受体激活的调节。
J Physiol. 2019 Oct;597(19):4927-4941. doi: 10.1113/JP278088. Epub 2019 Aug 28.
6
Evolution of hormone selectivity in glucocorticoid and mineralocorticoid receptors.糖皮质激素和盐皮质激素受体中激素选择性的演变。
J Steroid Biochem Mol Biol. 2013 Sep;137:57-70. doi: 10.1016/j.jsbmb.2013.07.009. Epub 2013 Jul 29.
7
Contribution of glucocorticoid-mineralocorticoid receptor pathway on the obesity-related adipocyte dysfunction.糖皮质激素-盐皮质激素受体通路在肥胖相关脂肪细胞功能障碍中的作用。
Biochem Biophys Res Commun. 2012 Mar 9;419(2):182-7. doi: 10.1016/j.bbrc.2012.01.139. Epub 2012 Feb 3.
8
Role of Pro-637 and Gln-642 in human glucocorticoid receptors and Ser-843 and Leu-848 in mineralocorticoid receptors in their differential responses to cortisol and aldosterone.Pro-637和Gln-642在人糖皮质激素受体中的作用以及Ser-843和Leu-848在盐皮质激素受体中对皮质醇和醛固酮的差异反应中的作用。
J Steroid Biochem Mol Biol. 2016 May;159:31-40. doi: 10.1016/j.jsbmb.2016.02.017. Epub 2016 Feb 22.
9
Adipocyte-derived factors regulate vascular smooth muscle cells through mineralocorticoid and glucocorticoid receptors.脂肪细胞衍生因子通过盐皮质激素和糖皮质激素受体调节血管平滑肌细胞。
Hypertension. 2011 Sep;58(3):479-88. doi: 10.1161/HYPERTENSIONAHA.110.168872. Epub 2011 Jul 25.
10
Increased glucocorticoid metabolism in diabetic kidney disease.糖尿病肾病中糖皮质激素代谢增加。
PLoS One. 2022 Jun 24;17(6):e0269920. doi: 10.1371/journal.pone.0269920. eCollection 2022.

引用本文的文献

1
Adipose Composition Before and After Primary Aldosteronism Treatment Depends on Primary Aldosteronism Subtypes and Plasma Aldosterone Concentration Before the Treatment.原发性醛固酮增多症治疗前后的脂肪成分取决于原发性醛固酮增多症的亚型及治疗前的血浆醛固酮浓度。
J Clin Hypertens (Greenwich). 2025 Jul;27(7):e70097. doi: 10.1111/jch.70097.
2
Metabolism disrupting effects in human pre-adipocytes: Influence of donor sex and body composition.对人类前脂肪细胞代谢的干扰作用:供体性别和身体组成的影响。
Toxicol Appl Pharmacol. 2025 Oct;503:117463. doi: 10.1016/j.taap.2025.117463. Epub 2025 Jul 16.
3
The Role of Cortisol and Dehydroepiandrosterone in Obesity, Pain, and Aging.

本文引用的文献

1
Deconstructing the roles of glucocorticoids in adipose tissue biology and the development of central obesity.解析糖皮质激素在脂肪组织生物学及中心性肥胖发展中的作用。
Biochim Biophys Acta. 2014 Mar;1842(3):473-81. doi: 10.1016/j.bbadis.2013.05.029. Epub 2013 Jun 2.
2
Glucocorticoids antagonize tumor necrosis factor-α-stimulated lipolysis and resistance to the antilipolytic effect of insulin in human adipocytes.糖皮质激素拮抗肿瘤坏死因子-α刺激的脂肪分解作用,并抵抗胰岛素的抗脂肪分解作用在人类脂肪细胞中。
Am J Physiol Endocrinol Metab. 2012 Nov 1;303(9):E1126-33. doi: 10.1152/ajpendo.00228.2012. Epub 2012 Sep 4.
3
皮质醇和脱氢表雄酮在肥胖、疼痛及衰老中的作用
Diseases. 2025 Feb 1;13(2):42. doi: 10.3390/diseases13020042.
4
In vitro endocrine and cardiometabolic toxicity associated with artificial turf materials.与人工草皮材料相关的体外内分泌和心脏代谢毒性。
Environ Toxicol Pharmacol. 2024 Oct;111:104562. doi: 10.1016/j.etap.2024.104562. Epub 2024 Sep 6.
5
Adipocyte Glucocorticoid Receptor Inhibits Immune Regulatory Genes to Maintain Immune Cell Homeostasis in Adipose Tissue.脂肪细胞糖皮质激素受体抑制免疫调节基因以维持脂肪组织中免疫细胞的稳态。
Endocrinology. 2023 Sep 23;164(11). doi: 10.1210/endocr/bqad143.
6
Chronic Stress as a Risk Factor for Type 2 Diabetes: Endocrine, Metabolic, and Immune Implications.慢性应激作为 2 型糖尿病的风险因素:内分泌、代谢和免疫影响。
Endocr Metab Immune Disord Drug Targets. 2024;24(3):321-332. doi: 10.2174/1871530323666230803095118.
7
Effects of Dietary Enrichment with Olive Cake on the Thyroid and Adrenocortical Responses in Growing Beef Calves.日粮添加橄榄饼对生长肉牛犊甲状腺和肾上腺皮质反应的影响
Animals (Basel). 2023 Jun 26;13(13):2120. doi: 10.3390/ani13132120.
8
Medical treatment of Cushing's disease with concurrent diabetes mellitus.库欣病合并糖尿病的治疗。
Front Endocrinol (Lausanne). 2023 Apr 17;14:1174119. doi: 10.3389/fendo.2023.1174119. eCollection 2023.
9
Corticosterone induces obesity partly promoting intestinal cell proliferation and survival.皮质酮通过促进肠道细胞增殖和存活在一定程度上诱发肥胖。
Front Endocrinol (Lausanne). 2023 Jan 9;13:1052487. doi: 10.3389/fendo.2022.1052487. eCollection 2022.
10
Obesity I: Overview and molecular and biochemical mechanisms.肥胖症 I:概述及分子与生化机制。
Biochem Pharmacol. 2022 May;199:115012. doi: 10.1016/j.bcp.2022.115012. Epub 2022 Apr 5.
A modified protocol to maximize differentiation of human preadipocytes and improve metabolic phenotypes.
一种改良的方案,用于最大限度地分化人类前体脂肪细胞并改善代谢表型。
Obesity (Silver Spring). 2012 Dec;20(12):2334-40. doi: 10.1038/oby.2012.116. Epub 2012 May 4.
4
Contribution of glucocorticoid-mineralocorticoid receptor pathway on the obesity-related adipocyte dysfunction.糖皮质激素-盐皮质激素受体通路在肥胖相关脂肪细胞功能障碍中的作用。
Biochem Biophys Res Commun. 2012 Mar 9;419(2):182-7. doi: 10.1016/j.bbrc.2012.01.139. Epub 2012 Feb 3.
5
Regulation of lipogenesis by glucocorticoids and insulin in human adipose tissue.糖皮质激素和胰岛素对人脂肪组织脂生成的调节。
PLoS One. 2011;6(10):e26223. doi: 10.1371/journal.pone.0026223. Epub 2011 Oct 14.
6
The effects of glucocorticoids on adipose tissue lipid metabolism.糖皮质激素对脂肪组织脂质代谢的影响。
Metabolism. 2011 Nov;60(11):1500-10. doi: 10.1016/j.metabol.2011.06.012. Epub 2011 Aug 23.
7
Aldosterone perturbs adiponectin and PAI-1 expression and secretion in 3T3-L1 adipocytes.醛固酮扰乱 3T3-L1 脂肪细胞中脂联素和 PAI-1 的表达和分泌。
Horm Metab Res. 2011 Jun;43(7):464-9. doi: 10.1055/s-0031-1277226. Epub 2011 Jun 10.
8
Pathways regulated by glucocorticoids in omental and subcutaneous human adipose tissues: a microarray study.糖皮质激素调控网膜和皮下人脂肪组织中通路的基因表达谱研究:一项基因芯片研究。
Am J Physiol Endocrinol Metab. 2011 Mar;300(3):E571-80. doi: 10.1152/ajpendo.00231.2010. Epub 2010 Dec 28.
9
Antiadipogenic effects of the mineralocorticoid receptor antagonist drospirenone: potential implications for the treatment of metabolic syndrome.醛固酮受体拮抗剂屈螺酮的抗脂肪生成作用:对代谢综合征治疗的潜在意义。
Endocrinology. 2011 Jan;152(1):113-25. doi: 10.1210/en.2010-0674. Epub 2010 Nov 17.
10
Adipogenic differentiation of adipose-derived stem cells.脂肪来源干细胞的成脂分化
Methods Mol Biol. 2011;702:193-200. doi: 10.1007/978-1-61737-960-4_14.